tiprankstipranks
Trending News
More News >
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market
Advertisement

PharmaCyte Biotech (PMCB) Income Statement

Compare
233 Followers

PharmaCyte Biotech Income Statement

Last quarter (Q1 2026), PharmaCyte Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, PharmaCyte Biotech's net income was $-8.36M. See PharmaCyte Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.38M$ 6.52M$ 6.46M$ 4.39M$ 3.62M
Depreciation and Amortization
$ 0.00$ 6.52M$ 6.46M$ 0.00$ 0.00
EBITDA
$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Operating Income
$ -4.38M$ -6.52M$ -6.46M$ -4.39M$ -3.62M
Other Income/Expenses
$ 35.03M$ 6.85M$ 2.14M$ 152.85K$ 71.75K
Pretax Income
$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Net Income
$ 30.66M$ 333.76K$ -4.32M$ -4.24M$ -3.55M
Per Share Metrics
Basic EPS
$ 3.19$ -1.80$ -0.22$ -0.27$ -2.46
Diluted EPS
$ 3.19$ -1.80$ -0.83$ -0.79$ -2.46
Weighted Average Shares Outstanding
7.33M 9.58M 19.49M 15.52M 1.45M
Weighted Average Shares Outstanding (Diluted)
7.33M 9.58M 5.18M 5.18M 1.45M
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis